BioCentury
ARTICLE | Company News

Agouron drops IMNR's Remune

July 6, 2001 7:00 AM UTC

The Immune Response Corp. (IMNR) was off $2.01 (44%) to $2.58 on Friday after Agouron, a subsidiary of Pfizer (PFE), terminated its collaboration for IMNR's Remune HIV-1 immunogen to treat HIV infecti...